Expanded InVEST safety panels up to 77 targets with 10-day turnaround
Preview text: Expanded InVEST safety panels: 18–77 targets, 10-day turnaround 96 Optimize drug safety…
No image available for this email.
- Subject
- Expanded InVEST safety panels up to 77 targets with 10-day turnaround
- Preview text
- Expanded InVEST safety panels: 18–77 targets, 10-day turnaround 96 Optimize drug safety…
- From
- hello@
marketing.reactionbiology.com - Brand
- Reaction Biology
- ESP
- HubSpot
- Sent
- Fri Mar 20, 2026, 8:33 AM ET
- Size
- 101 KB
- Images
- 6
- Links
- 19, 4 of them buttons
- Subject length
- 70 characters
Against Reaction Biology's usual
Sent in its busiest hour, 8 AM, which holds 80% of its emails. The subject is 70 characters; its average is 58.
Sent just before and after
| May 6, 2026 8:13 AM | Newsletter, move beyond the basics in immuno-oncology | |
| Apr 8, 2026 8:10 AM | Enhance drug safety testing with proven solutions 🦺 | |
| Apr 7, 2026 9:04 AM | NEW Publication and Webinar: 65,000 kinase-drug interactions mapped in new Nature Biotechnology study | |
| Apr 1, 2026 8:09 AM | Accelerate your ADC research with expert support | |
| Mar 26, 2026 8:16 AM | Newsletter, Visit Reaction Biology at AACR 2026 | |
| Mar 25, 2026 8:00 AM | ⚡ Get reliable in vivo testing results fast! ⚡ | |
| Mar 20, 2026 8:33 AM | Expanded InVEST safety panels up to 77 targets with 10-day turnaround (this email) |
More from Reaction Biology
All Reaction Biology emailsYour next hit deserves a better cell-based assay 🔬
Nov 11, 2026 8:06 AM
Subscriber, quickly map your compound’s kinase profile
Nov 4, 2026 8:06 AM
Enhance drug safety testing with proven solutions 🦺
Oct 28, 2026 8:08 AM
Accelerate your ADC research with expert support
Oct 21, 2026 8:07 AM
⚡ Get reliable in vivo testing results fast! ⚡
Oct 14, 2026 8:07 AM
Complete characterization across activity, binding, and cellular assays
Sep 10, 2026 8:33 AM





